Literature DB >> 28526391

Withdrawal from high-carbohydrate, high-saturated-fat diet changes saturated fat distribution and improves hepatic low-density-lipoprotein receptor expression to ameliorate metabolic syndrome in rats.

Ankita Hazarika1, Himadri Kalita1, Mohan Chandra Kalita2, Rajlakshmi Devi3.   

Abstract

OBJECTIVE: The "lipid hypothesis" determined that saturated fatty acid (SFA) raises low-density lipoprotein cholesterol, thereby increasing the risk for metabolic syndrome (MetS). The aim of this study was to investigate the effect of subchronic withdrawal from a high-carbohydrate, high-saturated fat (HCHF) diet during MetS with reference to changes in deleterious SFA (C12:0, lauric acid; C14:0, myristic acid; C16:0, palmitic acid; C18:0, stearic acid) distribution in liver, white adipose tissue (WAT), and feces.
METHODS: MetS induced by prolonged feeding of an HCHF diet in Wistar albino rat is used as a model of human MetS. The MetS-induced rats were withdrawn from the HCHF diet and changed to a basal diet for final 4 wk of the total experimental duration of 16 wk. SFA distribution in target tissues and hepatic low-density lipoprotein receptor (LDLr) expression were analyzed.
RESULTS: Analyses of changes in SFA concentration of target tissues indicate that C16:0 and C18:0 reduced in WAT and liver after withdrawal of the HCHF diet. There was a significant (P < 0.001) decrease in fecal C12:0 with HCHF feeding, which significantly (P < 0.01) increased after withdrawal of this diet. Also, an improvement in expression of hepatic LDLr was observed after withdrawal of HCHF diet.
CONCLUSION: The prolonged consumption of an HCHF diet leads to increased SFA accumulation in liver and WAT, decreased SFA excretion, and reduced hepatic LDLr expression during MetS, which is prominently reversed after subchronic withdrawal of the HCHF diet. This can contribute to better understanding of the metabolic fate of dietary SFA during MetS and may apply to the potential reversal of complications by the simple approach of nutritional modification.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  High-carbohydrate; High-saturated-fat; Lipid profile; Low-density lipoprotein receptor; Metabolic syndrome; Saturated fatty acid

Mesh:

Substances:

Year:  2017        PMID: 28526391     DOI: 10.1016/j.nut.2017.01.005

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  5 in total

1.  Hepatic glycogen participates in the regulation of hypothalamic pAkt/Akt ratio in high-sugar/high-fat diet-induced obesity.

Authors:  Breno P Casagrande; Allain A Bueno; Luciana P Pisani; Debora Estadella
Journal:  Metab Brain Dis       Date:  2022-03-22       Impact factor: 3.655

2.  Modulation of Dyslipidemia Markers Apo B/Apo A and Triglycerides/HDL-Cholesterol Ratios by Low-Carbohydrate High-Fat Diet in a Rat Model of Metabolic Syndrome.

Authors:  Abrar Alnami; Abdulhadi Bima; Aliaa Alamoudi; Basmah Eldakhakhny; Hussein Sakr; Ayman Elsamanoudy
Journal:  Nutrients       Date:  2022-05-01       Impact factor: 6.706

3.  Development of banana (Musa balbisiana) pseudo stem fiber as a surgical bio-tool to avert post-operative wound infections.

Authors:  Himadri Kalita; Ankita Hazarika; Raghuram Kandimalla; Sanjeeb Kalita; Rajlakshmi Devi
Journal:  RSC Adv       Date:  2018-10-31       Impact factor: 4.036

4.  Can Carob-Fruit-Extract-Enriched Meat Improve the Lipoprotein Profile, VLDL-Oxidation, and LDL Receptor Levels Induced by an Atherogenic Diet in STZ-NAD-Diabetic Rats?

Authors:  Adrián Macho-González; Alba Garcimartín; María Elvira López-Oliva; Baltasar Ruiz-Roso; Isabel Martín de la Torre; Sara Bastida; Juana Benedí; Francisco José Sánchez-Muniz
Journal:  Nutrients       Date:  2019-02-03       Impact factor: 5.717

5.  Association between dietary saturated fat with cardiovascular disease risk markers and body composition in healthy adults: findings from the cross-sectional BODYCON study.

Authors:  Ezgi Ozen; Rada Mihaylova; Michelle Weech; Sam Kinsella; Julie A Lovegrove; Kim G Jackson
Journal:  Nutr Metab (Lond)       Date:  2022-03-03       Impact factor: 4.169

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.